Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1438.75
-2.95 (-0.20%)
< Home < Back

Cipla informs about acquisition

Date: 16-07-2019

Cipla has informed that  Cipla (EU), UK, wholly owned subsidiary of the Company has entered into a joint venture agreement with Jiangsu Acebright Pharmaceutical Co. (Acebright), China on 15th July 2019 for incorporation of a company (JV Co.) in China.

The above information is a part of company’s filings submitted to BSE.